(TheNewswire)
Ottawa, ON - TheNewswire - March 11, 2022 - Molecule Holdings Inc. (CSE:MLCL ) (OTC:EVRRF) (“ Molecule ” or the“ Company ”), a Canadian craft-focused cannabis beverage productioncompany, is pleased to announce the launch of its newly revampedwebsite. The new website provides a refresheddesign, improved navigation, updated information, and mobile friendlyfunctionality. All our individual brand sites will intuitively linkoff the Molecule Corporate site to provide an in-depth picture of thebusiness while providing the look and feel of each brands individualnature.
Commented David Reingold, CEOMolecule, “ We are happy to have thisimportant project completed. Our corporate website and social channelsare a significant conduit for reaching and teaching consumers aboutour brands and the legal cannabis market. The comprehensive investorsection on the website is ideal for staying on top of company news andour evolving success. With this project firmly behind us, we are eagerto share our brand specific sites in the coming weeks.”
For further information, please contact:
André Audet, Chairman and Co-Founder Phone: 1 (888) 665-2853 x101
Email: andre@molecule.ca www.molecule.ca
About MoleculeHoldings Inc.
Molecule is a licensed producerdedicated to creating cannabis-infused beverages for the Canadianmarket. We produce leading, top-quality drinks to provide opportunityand choice to people seeking a convenient and social way to consumecannabis. Molecule is focused on growing both our portfolio, and theoverall cannabis beverage market. We want to ensure people have thebest opportunity to find exactly the product and experience theythirst for.
Neither the Canadian Securities Exchange nor itsregulation services provider accepts responsibility for the adequacyor accuracy of this press release.
Forward-Looking Statements
This press release containsstatements that constitute “forward-looking information”(“forward-looking information”) within the meaning of theapplicable Canadian securities legislation. All statements, other thanstatements of historical fact, are forward-looking information and arebased on expectations, estimates and projections as at the date ofthis news release. Any statement that discusses predictions,expectations, beliefs, plans, projections, objectives, assumptions,future events or performance (often but not always using phrases such as “expects”, or “does not expect”, “is expected”,“anticipates” or “does not anticipate”, “plans”, “budget”, “scheduled”, “forecasts”, “estimates”,“believes” or “intends” or variations of such words and phrases or stating that certain actions, events or results “may”or “could”, “would”, “might” or “will” be taken tooccur or be achieved) are not statements of historical fact and may beforward-looking information. Forward-looking statements in this newsrelease include statements relating to the new Molecule website; theanticipated functionality of the new website; the ability to findinformation on the website and that that information will be relevantand current. In disclosing the forward-looking information containedin this press release, the Company has made certainassumptions.
The Company's actual results coulddiffer materially from those anticipated in this forward-lookinginformation as a result of regulatory decisions, competitive factorsin the industries in which the Company operates, prevailing economicconditions, and other factors, many of which are beyond the control ofthe Company. The Company believes that the expectations reflected inthe forward-looking information are reasonable, but no assurance canbe given that these expectations will prove to be correct and suchforward-looking information should not be unduly relied upon. Anyforward-looking information contained in this news release representsthe Company's expectations as of the date hereof and is subject tochange after such date. The Company disclaims any intention orobligation to update or revise any forward-looking information whetheras a result of new information, future events or otherwise, except asrequired by applicable securities legislation.
Copyright (c) 2022 TheNewswire - All rights reserved.